On 8 February 2023 Alexey Repik, the founder of R-Pharm – Russian pharmaceutical company, producing, among other things, drugs for COVID-19 (e.g. coronavir (favipiravir) and artlegia (olokizumab)) was listed in the UK Sanctions List.

Reasoning behind this decision is that he holds the position of the Chairman of the Board of R-Pharm, which receives financing from the Russian Direct Investment Fund – a Government of Russia-affiliated entity. Moreover, Alexey Repik is also designated as a person associated with Vladimir Putin, the Russian President.

On January 17, 2023, a bill was submitted to the State Duma for consideration. This bill establishes higher responsibility for the sale of medicines subject to quantitative accounting without a prescription.

The relevant bill has been introduced in order to combat drug addiction, which is nowadays widespread, including among minors, as stipulated in explanatory note to the bill.

The new review of the most notable patents disputes in Life Sciences in EAEU.

• pdf, 1.56 Mb

The new General license No 6C published by OFAC on January 1, 2023, establishes exceptions from US sanctions related to the spheres of agricultural commodities, medicine, medical devices, replacement parts and components for medical devices, or software updates for medical devices.

Based on the Government Decree No. 593 of 5 April 2022 Multiagency Commission on the detection of medicines shortage or a risk of shortage included 88 INN in different forms and dosages (97 names in total) in the relevant list.

From September 01, 2023, changes in the procedure for conducting medical examinations before, during and after a workday (shift) come into force. Namely, starting from September, employers will be granted the right to conduct such examinations remotely – using medical devices that provide automated remote transmission of information about the health status of employees and remote monitoring of their health status.

On 5 December 2022, Federal Law “On Amendments to Article 56 of the Federal Law “On Circulation of Medicines” Regulating the Activities of production Pharmacies in Russia was officially published. 

On 2 December 2022 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. Lidings’ top position among the leading legal advisors in Russia once again reflected by the ranking results.

In October 2022, the European Commission approved the eighth package of sanctions against Russia. Among other restrictions it established a ban on the provision of legal services to Russian companies. A few weeks later, on October 24, the European Commission published answers to frequently asked questions including explanations as to what kind of legal services fall under the ban and whether the extension of sanctions to this sphere does not entail restrictions on the right to protection.

According to the official website of the Eurasian Patent Office (EAPO), the first national patent.